Literature DB >> 2010056

Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia.

A M Lefer1, P S Tsao, D J Lefer, X L Ma.   

Abstract

Endothelial dysfunction occurs after myocardial ischemia and reperfusion characterized by a marked reduction in endothelium-dependent relaxation (EDR) due to reduced release or action of endothelium-derived relaxing factor (EDRF). This reduced EDR occurs in coronary rings isolated from cats 2.5 min after reperfusion and in isolated perfused cat hearts 2.5 min after reperfusion. No decrease in EDR occurs before reperfusion in either preparation, suggesting that this impairment in EDR occurs during reperfusion. The decrease in EDR occurs soon after the generation of superoxide radicals by the reperfused coronary endothelium. Accumulation of neutrophils and myocardial cell injury does not occur until 3-4.5 h after reperfusion. Thus, endothelial generation of superoxide radicals acts as a trigger mechanism for endothelial dysfunction which is then amplified by neutrophil adherence and diapedesis into the ischemic region enhancing post-reperfusion ischemic injury. Agents that preserve endothelial function or inhibit neutrophil activation (e.g., superoxide dismutase, prostacyclin analogs, TGF-beta, antibodies to adhesive proteins) can protect against endothelial dysfunction and myocardial injury, if administered before reperfusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010056     DOI: 10.1096/fasebj.5.7.2010056

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  55 in total

1.  Reperfusion Injury: Idle Curiosity or Therapeutic Vector?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 2.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

3.  Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

Authors:  D Bani; E Masini; M G Bello; M Bigazzi; T B Sacchi
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  High renal ischemia temperature increases neutrophil chemoattractant production and tissue injury during reperfusion without an identifiable role for CD4 T cells in the injury.

Authors:  Nobuyuki Fukuzawa; Austin D Schenk; Marianne Petro; Katsuya Nonomura; William M Baldwin; Robert L Fairchild
Journal:  Transpl Immunol       Date:  2009-08-05       Impact factor: 1.708

5.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

Authors:  A Fox-Robichaud; D Payne; S U Hasan; L Ostrovsky; T Fairhead; P Reinhardt; P Kubes
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

6.  Drug-induced in vitro inhibition of neutrophil-endothelial cell adhesion.

Authors:  F Pellegatta; Y Lu; A Radaelli; M R Zocchi; E Ferrero; S Chierchia; G Gaja; M E Ferrero
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 7.  Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion.

Authors:  R M Egdell; T Siminiak; D J Sheridan
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

8.  Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts.

Authors:  D Ishii; A D Schenk; S Baba; R L Fairchild
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

9.  Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.

Authors:  J G Filep; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 10.  Noise and quality of life.

Authors:  Michael D Seidman; Robert T Standring
Journal:  Int J Environ Res Public Health       Date:  2010-10-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.